These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23985881)

  • 21. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
    Aguilar JL; Varshney AK; Pechuan X; Dutta K; Nosanchuk JD; Fries BC
    Virulence; 2017 Aug; 8(6):741-750. PubMed ID: 27715466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
    De Boer ML; Kum WW; Pang LT; Chow AW
    Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
    Bavari S; Ulrich RG; LeClaire RD
    J Infect Dis; 1999 Oct; 180(4):1365-9. PubMed ID: 10479174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in burned children.
    Childs C; Edwards Jones V; Dawson M; Davenport PJ
    Burns; 1999 Sep; 25(6):473-6. PubMed ID: 10498353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.
    Stiles BG; Krakauer T; Bonventre PF
    Infect Immun; 1995 Apr; 63(4):1229-34. PubMed ID: 7890377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
    Scott DF; Kling JM; Best GK
    Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.
    Kansal R; Davis C; Hansmann M; Seymour J; Parsonnet J; Modern P; Gilbert S; Kotb M
    J Clin Immunol; 2007 May; 27(3):327-38. PubMed ID: 17340193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.
    Krakauer T; Stiles BG
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):594-8. PubMed ID: 10391869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IgM antibodies to toxic shock syndrome toxin-1 in human sera and human immunoglobulins].
    Dickgiesser N; Düzgün F
    Klin Wochenschr; 1988 Jan; 66(1):7-11. PubMed ID: 3343806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.
    Hu DL; Cui JC; Omoe K; Sashinami H; Yokomizo Y; Shinagawa K; Nakane A
    Infect Immun; 2005 Jan; 73(1):174-80. PubMed ID: 15618152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
    Kunstmann G; Schröder E; Hasbach H; Pulverer G
    Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against lethal toxic shock by targeted disruption of the CD28 gene.
    Saha B; Harlan DM; Lee KP; June CH; Abe R
    J Exp Med; 1996 Jun; 183(6):2675-80. PubMed ID: 8676089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
    Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
    J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
    Bonventre PF; Weckbach L; Harth G; Haidaris C
    Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of glutathione S-transferase-fused mutant staphylococcal enterotoxin C against Staphylococcus aureus-induced bovine mastitis.
    Cui JC; Zhang BJ; Lin YC; Wang QK; Qian AD; Nakane A; Hu DL; Tong GZ
    Vet Immunol Immunopathol; 2010 May; 135(1-2):64-70. PubMed ID: 19959244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxin involvement in toxic shock syndrome.
    Crass BA; Bergdoll MS
    J Infect Dis; 1986 May; 153(5):918-26. PubMed ID: 3701106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.